iA Financial Group Named One of Canada's Best 50 Corporate Citizens for a Second Year
Corporate Knights' ranking of the world's best 50 Canadian corporate citizens is based on a rigorous assessment of publicly traded, privately owned, and Crown corporations in Canada with more than $1 billion in gross annual revenue across 25 key performance indicators covering resource management, sustainable revenue and investment, employee and financial management, and supplier performance.
'Being recognized as one of Canada's 50 Best Corporate Citizens is a source of pride for us, and a reminder of the importance of contributing to the wellbeing of our clients, employees and communities. This recognition also reflects the dedication of our employees who are committed to advancing our sustainability journey,' said Caroline Drouin, Senior Vice-President, Investor Relations, Sustainability and Public Affairs.
iA Financial Group specifically distinguished itself in terms of sustainable revenue, gender diversity on its Board of Directors, and wellbeing and personal development initiatives.
The Company has continued to decarbonize its investments and supports the introduction of stringent climate change regulations.
To learn more about sustainability at iA Financial Group, visit 2024 Sustainability Report.
About iA Financial Group
iA Financial Group is one of the largest insurance and wealth management groups in Canada, with operations in the United States. Founded in 1892, it is one of Canada's largest public companies. It is listed on the Toronto Stock Exchange under the ticker symbol IAG (common shares).
iA Financial Group is a business name and trademark of iA Financial Corporation Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
a minute ago
- Business Wire
DTLA Law Group Relocates to Former Lucky Brand HQ in Downtown Los Angeles
LOS ANGELES--(BUSINESS WIRE)-- DTLA Law Group is proud to announce the opening of its new headquarters on September 1, 2025, at 540 S. Santa Fe Avenue, in the vibrant Arts District of Downtown Los Angeles. Formerly the home of Lucky Brand, the newly renovated 52,000-square-foot space reflects not only the growth of the firm, but a deeper commitment to justice, service, and community. 'This move is about more than square footage or a change in address,' said Farid Yaghoubtil, Founder of DTLA Law Group. 'This move is about more than square footage or a change in address,' said Farid Yaghoubtil, Founder of DTLA Law Group. 'It's about expanding our mission and making sure that working people, immigrants, families, and everyday Angelenos have access to the same level of legal firepower as the most powerful institutions in this city.' The new space features a thoughtful balance of modern efficiency and human connection, including open workspaces for collaboration, private rooms for focused advocacy, and dedicated, secure areas for client meetings. It is a place designed to listen, to build, and to fight for those who often feel unheard. This relocation marks the next chapter in DTLA Law Group's mission-driven journey. For more than a decade, the firm has advocated for the injured, the vulnerable, and those whose voices often go unheard. From personal injury claims to complex civil rights cases, DTLA Law Group has successfully handled thousands of matters across California. 'Justice shouldn't be determined by wealth or status — it should be accessible to everyone,' added Yaghoubtil. 'This new space enables us to uphold that belief more effectively, every single day.' The office integrates sustainability and technology, with upgraded systems and energy-efficient infrastructure. Staff amenities include a café, quiet lounges, and breakout zones to support the team's wellness, creativity, and focus. This move also signals a deeper investment in the future. DTLA Law Group is growing, adding new attorneys, expanding its litigation footprint, and continuing to take on high-impact cases. However, growth is not the end goal—impact is. Impact on communities, on families, and on the legal landscape across California. About DTLA Law Group DTLA Law Group is a full-service civil litigation firm based in Downtown Los Angeles. The firm represents plaintiffs in personal injury and a wide range of complex legal matters. Known for its multilingual support, tireless advocacy, and commitment to client-centered justice, DTLA Law Group remains devoted to one thing above all else: standing up for everyday people—and delivering results that change lives.
Business Wire
a minute ago
- Business Wire
Lyten to Acquire All Remaining Northvolt Assets in Sweden and Germany
SAN JOSE, Calif. & STOCKHOLM & HEIDE, Germany--(BUSINESS WIRE)--Lyten, the global leader in lithium-sulfur batteries, announced today that it has entered into a binding agreement to acquire Northvolt's remaining assets in Sweden and Germany. The acquisition includes Northvolt Ett and Ett Expansion (Skellefteå, Sweden), Northvolt Labs (Västerås, Sweden), and Northvolt Drei (Heide, Germany). Additionally, Lyten is acquiring all remaining Northvolt intellectual property (IP), and multiple members of the current Northvolt executive team plan to join Lyten. The financial terms of the agreement were not disclosed by any parties. 'This is a defining moment for Lyten,' stated Dan Cook, Lyten CEO and Co-Founder. 'Lyten's mission is to be the leading supplier of clean, locally sourced and manufactured batteries and energy storage systems in both North America and Europe. The acquisition of Northvolt's assets brings the facilities and Swedish talent to accelerate this mission by years, just at the moment when demand for Lyten lithium-sulfur batteries is growing exponentially to meet energy independence, national security, and AI data center needs.' In total, Lyten's acquisition includes assets valued at approximately $5B, including 16 GWh of existing battery manufacturing capacity, more than 15 GWh of capacity under construction, the infrastructure and plans to scale to more than 100 GWh, and the largest and most advanced battery R&D center (Västerås) in Europe. Lyten plans to rehire a significant portion of the previously laid-off workforce at these facilities and will assess staffing needs site by site. Lyten sees substantial value in retaining local expertise and is committed to building long-term employment opportunities as we restart and scale operations. Ebba Busch, Deputy Prime Minister of Sweden, stated 'Lyten's acquisition of the Northvolt assets is a win for Sweden, for the former employees of Northvolt, and for positioning Sweden as key to Europe's energy independence. We have been working closely with the Trustee and Lyten to fully support this deal and we are excited to work with Lyten moving forward to make good on the immense potential of these assets.' This acquisition is being fully funded through equity investment into Lyten from private investors. The transactions are subject to appropriate Swedish and German governmental and European agency approvals. Lyten expects the acquisitions to close in the fourth quarter of this year. Lyten has previously announced the acquisition of three other Northvolt assets. In November 2024, Lyten acquired Northvolt's Cuberg battery manufacturing facility in California. In early July, Lyten announced the acquisition of Northvolt Dwa, Europe's largest Battery Energy Storage System (BESS) manufacturing facility, located in Gdansk, Poland. The acquisition is expected to close in August 2025. And in late July, Lyten acquired Northvolt's BESS product and IP portfolio. Lyten plans to immediately restart operations in Skellefteå (Ett) and Västerås (Labs) upon close of the transaction and collaboration with Northvolt's prior anchor customers is progressing constructively. Lyten plans to immediately restart Northvolt Dwa upon close of the transaction to support rapidly growing demand for Lyten BESS in more than 20 countries. At Northvolt Drei, Lyten is working with Northvolt and the German government to continue the program to establish a battery manufacturing facility near Heide in Schleswig-Holstein, with 15 GWh of initial capacity. Lyten is also committed to pursuing the acquisition of Northvolt Six in Quebec, Canada, which is constructing a 15 GWh Phase 1 battery manufacturing facility. Lyten is actively progressing discussions with Northvolt North America, the Government of Canada, the Government of Québec and other key local stakeholders. 'The demand for European and North American made batteries is only growing,' added Lars Herlitz, Lyten Chairman and Co-Founder. 'The combination of Northvolt's world-class manufacturing assets and low-cost clean energy, Lyten's world leading lithium-sulfur battery technology, and Lyten's U.S. battery materials supply chain creates the right formula to fulfill Europe and North America's battery manufacturing ambitions.' Lyten currently manufactures lithium-sulfur batteries in Silicon Valley and is selling commercially into the rapidly growing drone and defense markets. Lyten is also preparing to launch its lithium-sulfur batteries onto the International Space Station in the coming months and has a multi-billion-dollar pipeline for BESS powered by lithium-sulfur. 'Lyten is a leader in the energy storage industry. As energy becomes a national security priority, from data centers to micro-grids, I'm proud to help secure a sustainable transformation of Germany's infrastructure and data economy.' stated Sem M. Köksal, Lyten Advisor and CEO Gsl Holding GmbH. The Trustee, Lyten, and Northvolt will be hosting a press conference in Skellefteå at 10:30am CET on Friday, August 8 to share more information about the transaction. The press conference will be live streamed at About Lyten Lyten, founded in 2015, is a supermaterial applications company that has received more than $625 million in equity investment and secured LOIs for $650M in financing from the Export Import Bank of the US. Lyten has built a proprietary materials platform, called Lyten 3D Graphene, that it uses to build better performing, lower cost, and decarbonizing products, including its next generation lithium-sulfur battery. Lyten corporate headquarters is in San Jose, CA and European headquarters is in Luxembourg. The company lists more than 540 patents granted or pending and is currently manufacturing in San Jose, CA. In November 2024, Lyten announced the acquisition of Northvolt's battery manufacturing plant in San Leandro, California to scale production to meet the demand for American made batteries. In 2024, Lyten announced its integration into Chrysler's Halcyon Concept electric vehicle and the selection of Lyten Lithium-Sulfur for demonstration on-orbit aboard the International Space Station (ISS), scheduled for launch later in 2025. Lyten is selling lithium-sulfur commercially into the rapidly growing drone and defense market. Lyten was named Fast Company's #8 Most Innovative Energy Company and named one of America's Top Green Technology Companies by Time in 2024, 2025, and been named to Silicon Valley Defense Journal's Top 100 National Security Companies from 2023 – 2025.
Business Wire
a minute ago
- Business Wire
Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News: Celyad Oncology (Euronext: CYAD) (the 'Company' or 'Celyad Oncology'), today announces the below information following the issuance, on August 5, 2025, of 3,333,333 new shares of Celyad Oncology to an affiliate of Fortress Investment Group. As a result, the Company's share capital has been increased to 9,216,154.53 EUR and is represented by 44,761,905 shares. This information is published in accordance with Article 15 of the Belgian Law of 2 May 2007 on the disclosure of major participations in issuers whose shares are admitted to trading on a regulated market and regarding miscellaneous provisions. Figures – Modified on August 5, 2025, following the capital increase: Contact person for regulated information (financial, transparency) By law, any transparency declaration must be sent to our Company by email to the attention of Matthew Kane, Chief Executive Officer (CEO): investors@ Further questions about the content of this release can be sent to investors@ About Celyad Oncology Celyad Oncology is a cutting-edge biotechnology company focused primarily on unlocking the potential of its proprietary CAR-T technology platforms and intellectual property. The Company is headquartered in Mont-Saint-Guibert, Belgium. For more information, visit Celyad Oncology Forward-Looking Statement This release may contain forward-looking statements, including, without limitation, statements regarding beliefs about and expectations for the Company's updated strategic business model, including associated potential benefits, transactions and partnerships, statements regarding the potential value of the Company's IP, statements regarding the Company's financial statements and cash runway, statements regarding the Company's future fundraising plans, statements regarding the Company's hiring plans, and statements regarding the continuation of the Company's existence. The words 'will,' 'potential,' 'continue,' 'target,' 'project,' 'should' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this release are based on management's current expectations and beliefs and are subject to a number of known and unknown risks, uncertainties and important factors which might cause actual events, results, financial condition, performance or achievements of Celyad Oncology to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks related to the material uncertainty about the Company's ability to continue as a going concern; the Company's ability to realize the expected benefits of its updated strategic business model; the Company's ability to develop its IP assets and enter into partnerships with outside parties; the Company's ability to enforce its patents and other IP rights; the possibility that the Company may infringe on the patents or IP rights of others and be required to defend against patent or other IP rights suits; the possibility that the Company may not successfully defend itself against claims of patent infringement or other IP rights suits, which could result in substantial claims for damages against the Company; the possibility that the Company may become involved in lawsuits to protect or enforce its patents, which could be expensive, time-consuming, and unsuccessful; the Company's ability to protect its IP rights throughout the world; the potential for patents held by the Company to be found invalid or unenforceable; and other risks identified in the latest Annual Report of Celyad Oncology. These forward-looking statements speak only as of the date of publication of this document and Celyad Oncology's actual results may differ materially from those expressed or implied by these forward-looking statements. Celyad Oncology expressly disclaims any obligation to update any such forward-looking statements in this document to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based, unless required by law or regulation.
